Empowered Funds
MNOV icon

Empowered Funds’s MediciNova MNOV Stock Holding History

Empowered Funds’s Portfolio MNOV Stock Details MNOV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$82.8K Buy
+49,430
New +$81.3K ﹤0.01% 2434

Other funds holding MNOV

Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.76T AUM
Essex Woodlands Management
Essex Woodlands Management The Woodlands, Texas $323M AUM 25.39% 1-Year Est. Return
BlackRock
BlackRock New York $6.79T AUM 37.06% 1-Year Est. Return
Citigroup
Citigroup New York $308B AUM 40.94% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $463B AUM
Renaissance Technologies
Renaissance Technologies New York $73.4B AUM 32.8% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return
Jane Street
Jane Street New York $1.19T AUM 51.51% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return

Empowered Funds's MNOV Position: Q3 2026 in Review

Empowered Funds opened a new position in MediciNova (MNOV) in Q3 2026: 49,430 shares worth $82.8K. The stake represents ﹤0.01% of the portfolio and ranks #2434 among its holdings.

29 funds tracked by Wall St. Rank hold MNOV as of Q3 2026.

  • Empowered Funds held 49,430 shares of MediciNova worth $82.8K as of Q3 2026.
  • MediciNova was a new Empowered Funds position in Q3 2026.
  • MediciNova made up ﹤0.01% of Empowered Funds's portfolio in Q3 2026, its #2434 holding.
  • 29 funds tracked by Wall St. Rank held MediciNova as of Q3 2026.

Based on Empowered Funds's 13F filing for Q3 2026, filed 13 Nov 2026.